Literature DB >> 15843374

Application of the "codon-shuffling" method. Synthesis and selection of de novo proteins as antibacterials.

Alka Rao1, Sidharth Chopra, Geeta Ram, Ankit Gupta, Anand Ranganathan.   

Abstract

Library-based methods of non-rational and part-rational designed de novo peptides are worthy beacons in the search for bioactive peptides and proteins of medicinal importance. In this report, we have used a recently developed directed evolution method called "codon shuffling" for the synthesis and selection of bioactive proteins. The selection of such proteins was based on the creation of an inducible library of "codon-shuffled" genes that are constructed from the ligation-based assembly of judiciously designed hexamer DNA duplexes called dicodons. Upon induction with isopropyl 1-thio-beta-D-galactopyranoside, some library members were found to express dicodon-incorporated proteins. Because of this, the host cells, in our case Escherichia coli, were unable to grow any further. The bactereostatic/lytic nature of the dicodon proteins was monitored by growth curves as well as by zone clearance studies. Transmission electron microscopy of the affected cells illustrated the extent of cell damage. The proteins themselves were overexpressed as fusion partners and subsequently purified to homogeneity. One such purified protein was found to strongly bind heparin, an indication that the interaction of the de novo proteins may be with the nucleic acids of the host cell, much like many of the naturally occurring antibacterial peptides, e.g. Buforin. Therefore, our approach may help in generating a multitude of finely tuned antibacterial proteins that can potentially be regarded as lead compounds once the method is extended to pathogenic hosts, such as Mycobacteria, for example.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15843374     DOI: 10.1074/jbc.M503056200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Synthesis and selection of de novo proteins that bind and impede cellular functions of an essential mycobacterial protein.

Authors:  Alka Rao; Geeta Ram; Adesh Kumar Saini; Reena Vohra; Krishan Kumar; Yogendra Singh; Anand Ranganathan
Journal:  Appl Environ Microbiol       Date:  2006-12-22       Impact factor: 4.792

Review 2.  Synthetic Biology and Computer-Based Frameworks for Antimicrobial Peptide Discovery.

Authors:  Marcelo D T Torres; Jicong Cao; Octavio L Franco; Timothy K Lu; Cesar de la Fuente-Nunez
Journal:  ACS Nano       Date:  2021-02-04       Impact factor: 15.881

3.  A three-hybrid system to probe in vivo protein-protein interactions: application to the essential proteins of the RD1 complex of M. tuberculosis.

Authors:  Megha Tharad; Sachin Kumar Samuchiwal; Kuhulika Bhalla; Anamika Ghosh; Krishan Kumar; Sushil Kumar; Anand Ranganathan
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

4.  Human Cyclophilin B forms part of a multi-protein complex during erythrocyte invasion by Plasmodium falciparum.

Authors:  Prem Prakash; Mohammad Zeeshan; Ekta Saini; Azhar Muneer; Sachin Khurana; Bishwanath Kumar Chourasia; Arunaditya Deshmukh; Inderjeet Kaur; Surabhi Dabral; Niharika Singh; Zille Anam; Ayushi Chaurasiya; Shikha Kaushik; Pradeep Dahiya; Md Kalamuddin; Jitendra Kumar Thakur; Asif Mohmmed; Anand Ranganathan; Pawan Malhotra
Journal:  Nat Commun       Date:  2017-11-16       Impact factor: 14.919

5.  Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria.

Authors:  Rolf Hirsch; Jochen Wiesner; Armin Bauer; Alexander Marker; Heiko Vogel; Peter Eugen Hammann; Andreas Vilcinskas
Journal:  Microorganisms       Date:  2020-04-25

6.  Phenylalanine-rich peptides potently bind ESAT6, a virulence determinant of Mycobacterium tuberculosis, and concurrently affect the pathogen's growth.

Authors:  Krishan Kumar; Megha Tharad; Swetha Ganapathy; Geeta Ram; Azeet Narayan; Jameel Ahmad Khan; Rana Pratap; Anamika Ghosh; Sachin Kumar Samuchiwal; Sushil Kumar; Kuhulika Bhalla; Deepti Gupta; Krishnamurthy Natarajan; Yogendra Singh; Anand Ranganathan
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.